Patients with Obesity Call for Fair Drug Standards: New Research Reveals Strong Demand for FDA and Industry Action on Testing and Labeling

At ObesityWeek 2025, new data show overwhelming public support for ensuring that all medications are evaluated and labeled for safety and efficacy in people with obesity. ATLANTA, Nov. 4, 2025 /PRNewswire/ -- New research presented today at ObesityWeek 2025, the world's leading...